China Medicine Corporation
Symbol: CHME
PNK
0.028
USDDzisiejsza cena rynkowa
0.0009
Wskaźnik P/E
-0.0001
Wskaźnik PEG
79.67M
Kapitalizacja MRK
- 0.00%
Rentowność DIV
China Medicine Corporation (CHME) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.5 | 2.8 | 5.8 | ||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.net-receivables | 0 | 22.3 | 19.8 | 13.6 | ||||||
balance-sheet.row.inventory | 0 | 2.7 | 4.7 | 3.9 | ||||||
balance-sheet.row.other-current-assets | 0 | 0.5 | 6.3 | 6.1 | ||||||
balance-sheet.row.total-current-assets | 0 | 30.3 | 33.7 | 29.4 | ||||||
balance-sheet.row.property-plant-equipment-net | 0 | 12 | 3.8 | 1.4 | ||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.long-term-investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 6 | 0.7 | ||||||
balance-sheet.row.total-non-current-assets | 0 | 36.6 | 11 | 3.2 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.account-payables | 0 | 1.3 | 0.1 | 0 | ||||||
balance-sheet.row.short-term-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0.8 | 0 | ||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 0 | 0.5 | 1 | 0.9 | ||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.9 | 0 | 0 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-liab | 0 | 21.3 | 1.1 | 0.9 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 0 | 22.9 | 22.1 | 14 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 4.4 | 4.4 | 4.3 | ||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 17.7 | 16.2 | 12.6 | ||||||
balance-sheet.row.total-stockholders-equity | 0 | 45 | 42.8 | 30.9 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.minority-interest | 0 | 0.5 | 0.8 | 0.9 | ||||||
balance-sheet.row.total-equity | 0 | 45.5 | 43.6 | 31.8 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||
Total Investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.total-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.net-debt | 0 | 9 | -2.8 | -5.8 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1.4 | 9.1 | 6.9 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 0.1 | 0 | ||||||
cash-flows.row.change-in-working-capital | 0 | 7.1 | -5.4 | -10.1 | ||||||
cash-flows.row.account-receivables | 0 | -2.3 | -4.8 | 0 | ||||||
cash-flows.row.inventory | 0 | 3.4 | -0.5 | -1.8 | ||||||
cash-flows.row.account-payables | 0 | 0.6 | 0 | 0 | ||||||
cash-flows.row.other-working-capital | 0 | 5.4 | -0.1 | -8.2 | ||||||
cash-flows.row.other-non-cash-items | 0 | 7.3 | -0.1 | 0.1 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.acquisitions-net | 0 | -8 | 0 | 0 | ||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -5.2 | 0 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-investing-activites | 0 | -1.9 | 0 | 0 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -13.5 | -7.9 | -0.4 | ||||||
cash-flows.row.debt-repayment | 0 | -10.6 | 0 | 0 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 7.8 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.4 | 0 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -5.7 | 0.4 | 7.8 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.3 | 0.3 | ||||||
cash-flows.row.net-change-in-cash | 0 | -2.3 | -3 | 5.4 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 0.5 | 2.8 | 5.8 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2.8 | 5.8 | 0.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | 17 | 4.2 | -2.3 | ||||||
cash-flows.row.capital-expenditure | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.free-cash-flow | 0 | 13.3 | 1.5 | -2.7 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 64.8 | 53.6 | 42.1 | ||||||
income-statement-row.row.cost-of-revenue | 0 | 45.8 | 38.1 | 29.7 | ||||||
income-statement-row.row.gross-profit | 0 | 19 | 15.6 | 12.4 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.operating-expenses | 0 | 6.7 | 4.6 | 4 | ||||||
income-statement-row.row.cost-and-expenses | 0 | 52.5 | 42.7 | 33.7 | ||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.total-operating-expenses | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||
income-statement-row.row.operating-income | 0 | 12.3 | 10.9 | 8.4 | ||||||
income-statement-row.row.income-before-tax | 0 | 5 | 11 | 8.4 | ||||||
income-statement-row.row.income-tax-expense | 0 | 3.5 | 2 | 1.6 | ||||||
income-statement-row.row.net-income | 0 | 1.7 | 9.1 | 6.9 |
Często zadawane pytania
Ile wynosi China Medicine Corporation (CHME) aktywów ogółem?
China Medicine Corporation (CHME) całkowite aktywa to 66844482.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.293.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.870.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.027.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.189.
Co to jest China Medicine Corporation (CHME) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 1717677.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 9506160.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 6718099.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.